MHSPC
Clinical trials for MHSPC explained in plain language.
Never miss a new study
Get alerted when new MHSPC trials appear
Sign up with your email to follow new studies for MHSPC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New oral drug tested alongside standard therapy for advanced prostate cancer
Disease control Not yet recruitingThis early-stage study aims to test the safety and initial effectiveness of an investigational oral drug called LC-K76 when given alongside standard hormone therapy to men with newly diagnosed metastatic prostate cancer. The trial will involve about 40 participants who will take …
Matched conditions: MHSPC
Phase: EARLY_PHASE1 • Sponsor: Shanghai Changzheng Hospital • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
New combo aims to control advanced prostate cancer with less chemo
Disease control Not yet recruitingThis study is testing whether a combination of three drugs can effectively control metastatic prostate cancer while using a lower dose of chemotherapy. It will involve about 109 men whose cancer has spread beyond the prostate. The main goal is to see if this approach can reduce a…
Matched conditions: MHSPC
Phase: PHASE2 • Sponsor: Yonghong Li • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
Blood test could guide prostate cancer care
Knowledge-focused Not yet recruitingThis study aims to see if a personalized blood test can predict how well treatments work for men with advanced prostate cancer that has spread. Researchers will follow 50 newly diagnosed patients to see if the test, which looks for tiny amounts of leftover cancer, can tell which …
Matched conditions: MHSPC
Sponsor: Anhui Medical University • Aim: Knowledge-focused
Last updated Mar 16, 2026 15:26 UTC